BUB
GILD icon

BBVA USA Bancshares’s Gilead Sciences GILD Stock Holding History

BBVA USA Bancshares’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$2.2M Sell
34,033
-191
-0.6% -$12.3K 0.1% 186
2020
Q4 		$1.99M Sell
34,224
-14,752
-30% -$890K 0.1% 185
2020
Q3 		$3.14M Sell
48,976
-4,098
-8% -$284K 0.18% 126
2020
Q2 		$4.08M Buy
53,074
+2,076
+4% +$159K 0.24% 100
2020
Q1 		$3.81M Buy
50,998
+17,673
+53% +$1.22M 0.27% 90
2019
Q4 		$2.17M Buy
33,325
+1,390
+4% +$90.5K 0.12% 162
2019
Q3 		$2.02M Buy
31,935
+1,358
+4% +$88.8K 0.13% 164
2019
Q2 		$2.07M Buy
30,577
+1,717
+6% +$113K 0.12% 160
2019
Q1 		$1.88M Buy
28,860
+2,920
+11% +$194K 0.12% 168
2018
Q4 		$1.62M Sell
25,940
-9,680
-27% -$677K 0.12% 172
2018
Q3 		$2.75M Buy
35,620
+1,881
+6% +$142K 0.16% 136
2018
Q2 		$2.39M Buy
33,739
+15,143
+81% +$1.07M 0.15% 147
2018
Q1 		$1.4M Buy
18,596
+6,803
+58% +$541K 0.09% 215
2017
Q4 		$844K Sell
11,793
-1,564
-12% -$119K 0.05% 297
2017
Q3 		$1.08M Buy
13,357
+3,235
+32% +$247K 0.07% 250
2017
Q2 		$717K Sell
10,122
-728
-7% -$48.4K 0.05% 316
2017
Q1 		$737K Sell
10,850
-1,698
-14% -$119K 0.05% 308
2016
Q4 		$899K Sell
12,548
-8,624
-41% -$641K 0.06% 270
2016
Q3 		$1.68M Sell
21,172
-560
-3% -$45.5K 0.12% 169
2016
Q2 		$1.81M Sell
21,732
-4,173
-16% -$370K 0.14% 153
2016
Q1 		$2.38M Sell
25,905
-11,808
-31% -$1.06M 0.18% 128
2015
Q4 		$3.82M Buy
37,713
+33
+0.1% +$3.43K 0.28% 93
2015
Q3 		$3.7M Buy
37,680
+2,639
+8% +$293K 0.29% 93
2015
Q2 		$4.1M Buy
35,041
+11,117
+46% +$1.21M 0.23% 115
2015
Q1 		$2.35M Buy
23,924
+9,230
+63% +$937K 0.1% 181
2014
Q4 		$1.39M Buy
14,694
+8,803
+149% +$910K 0.06% 233
2014
Q3 		$627K Buy
5,891
+1,973
+50% +$193K 0.03% 349
2014
Q2 		$325K Sell
3,918
-41
-1% -$3.19K 0.01% 471
2014
Q1 		$281K Buy
+3,959
New +$310K 0.01% 471

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BBVA USA Bancshares's GILD Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Gilead Sciences (GILD) stake by 0.56% in Q1 2021, selling an estimated $12.3K and leaving 34,033 shares worth $2.2M. The position accounts for 0.1% of the portfolio, ranked #186.

BBVA USA Bancshares first reported a position in GILD in Q1 2014 and has held it in 29 quarters since. The position peaked at $4.1M in Q2 2015. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • BBVA USA Bancshares held 34,033 shares of Gilead Sciences worth $2.2M as of Q1 2021.
  • BBVA USA Bancshares sold 191 Gilead Sciences shares in Q1 2021, an estimated $12.3K.
  • Gilead Sciences made up 0.1% of BBVA USA Bancshares's portfolio in Q1 2021, its #186 holding.
  • BBVA USA Bancshares first reported a position in Gilead Sciences in Q1 2014 and has held it in 29 quarters since.
  • BBVA USA Bancshares's Gilead Sciences position peaked at $4.1M in Q2 2015.
  • 1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.